If Dave is a candidate for the clinical trial it would be A Phase 2 Study of Paclitaxel with Cisplatin vs Fluorpyrimidine with a Platinum Agent for NeoadjuvantTherapy in Operable Esophogeal Cancer Based on CHFR Methylation Status in Diagnostic Biopsies".